Kidney drug study aims to understand dosing, not cure
NCT ID NCT07348237
First seen Jan 17, 2026 · Last updated May 08, 2026 · Updated 11 times
Summary
This study looks at how the drug MK-2828 behaves in the bodies of people with different levels of kidney function, including those on dialysis. About 24 adults will receive one or two doses, and researchers will track the drug levels in their blood over time. The goal is to see if kidney disease changes how the drug is processed, which can help guide future dosing. This is not a treatment study—participants receive the drug only for measurement purposes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Floridian Clinical Research ( Site 0001)
RECRUITINGMiami Lakes, Florida, 33016, United States
Contact Phone: •••-•••-••••
-
Orlando Clinical Research Center ( Site 0002)
RECRUITINGOrlando, Florida, 32809, United States
Contact Phone: •••-•••-••••
-
Panax Clinical Research ( Site 0003)
RECRUITINGMiami Lakes, Florida, 33014, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.